Serotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway

Molecular and Cellular Biochemistry

Volumn 372, Issue 1-2, 2013, Pages 211-220

  Coelho, Wagner Santos ^a   Sola Penna, Mauro ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Glycolysis; Hormone; Metabolism; Phosphofructokinase; Regulation

Indexed keywords

6 PHOSPHOFRUCTOKINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; JANUS KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; GLUCOSE TRANSPORT; GLYCOLYSIS; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; GLUCOSE; JANUS KINASE 2; MALE; MICE; MUSCLE, SKELETAL; PHORBOL ESTERS; PHOSPHOFRUCTOKINASE-1; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEROTONIN; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TYPE C PHOSPHOLIPASES;

MUS;

EID: 84870407425     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1462-0     Document Type: Article

References (76)

1. Leysen JE (2004) 5-HT2 receptors. Curr Drug Targets CNS Neurol Disord 3:11-26
2. 2A receptor density and associative learning. Psychopharmacology 172:435-442. doi: 10.1007/s00213-003-1687-4
3. 2C receptors. Pharmacol Ther 121:160-173. doi: 10.1016/j.pharmthera. 2008.10.010
4. Roth BL, Willins DL, Kristiansen K, Kroeze WK (1998) 5- Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5- hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol Ther 79:231-257
5. 2A receptor. J Neurochem 63:465-469
6. Hajduch E, Rencurel F, Balendran A, Batty IH, Downes CP, Hundal HS (1999) Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem 274:13563-13568
7. 2A (serotonin) receptor in rat skeletal muscle. Biochem Biophys Res Commun 257:369-372
8. Assouline-Cohen M, Ben-Porat H, Beitner R (1998) Activation of membrane skeleton-bound phosphofructokinase in erythrocytes induced by serotonin. Mol Genet Metab 63:235-238
9. 2A receptor. Am J Physiol 268:F122-F127
10. 2A receptor coupled to the Jak/STAT pathway. J Biol Chem 272:14825-14829
11. Banes AK, Shaw SM, Tawfik A, Patel BP, Ogbi S, Fulton D, Marrero MB (2005) Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin. Am J Physiol Cell Physiol 288:C805-C812. doi: 10.1152/ajpcell.00385. 2004
12. Azmitia EC (2001) Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56:413-424
13. Sola-Penna M, Da Silva D, Coelho WS, Marinho-Carvalho MM, Zancan P (2010) Regulation of mammalian muscle type 6-phosphofructo-1-kinase and its implication for the control of the metabolism. IUBMB Life 62:791-796. doi: 10.1002/iub.393
14. Coelho WS, Costa KC, Sola-Penna M (2007) Serotonin stimulates mouse skeletal muscle 6-phosphofructo-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization. Mol Genet Metab 92:364-370
15. Coelho WS, Da Silva D, Marinho-Carvalho MM, Sola-Penna M (2012) Serotonin modulates hepatic 6-phosphofructo-1-kinase in an insulin synergistic manner. Int J Biochem Cell Biol 44:150-157. doi: 10.1016/j.biocel.2011.10.010
16. Luther MA, Lee JC (1986) The role of phosphorylation in the interaction of rabbit muscle phosphofructokinase with F-actin. J Biol Chem 261:1753-1759
17. Kuo HJ, Malencik DA, Liou RS, Anderson SR (1986) Factors affecting the activation of rabbit muscle phosphofructokinase by actin. Biochemistry 25:1278-1286
18. Alves GG, Sola-Penna M (2003) Epinephrine modulates cellular distribution of muscle phosphofructokinase. Mol Genet Metab 78:302-306
19. Silva AP, Alves GG, Araujo AH, Sola-Penna M (2004) Effects of insulin and actin on phosphofructokinase activity and cellular distribution in skeletal muscle. An Acad Bras Cienc 76:541-548
20. Zancan P, Sola-Penna M (2005) Calcium influx: a possible role for insulin modulation of intracellular distribution and activity of 6-phosphofructo-1- kinase in human erythrocytes. Mol Genet Metab 86:392-400
21. Zancan P, Sola-Penna M (2005) Regulation of human erythrocyte metabolism by insulin: cellular distribution of 6-phosphofructo-1-kinase and its implication for red blood cell function. Mol Genet Metab 86:401-411
22. Real-Hohn A, Zancan P, Da Silva D, Martins ER, Salgado LT, Mermelstein CS, Gomes AM, Sola-Penna M (2010) Filamentous actin and its associated binding proteins are the stimulatory site for 6-phosphofructo-1-kinase association within the membrane of human erythrocytes. Biochimie 92:538-544. doi: 10.1016/j.biochi.2010.01.023
23. Maia JCC, Gomes SL, Juliani MH, Morel CM (1983) Preparation of [γ-32 P] and [α-32 P]-nucleoside triphosphate, with high specific activity. In: Morel CM (ed) Genes and antigenes of parasites: a laboratory manual. FIOCRUZ, Rio de Janeiro, pp 146-157
24. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
25. Sola-Penna M, dos Santos AC, Alves GG, El-Bacha T, Faber-Barata J, Pereira MF, Serejo FC, Da Poian AT, Sorenson M (2002) A radioassay for phosphofructokinase-1 activity in cell extracts and purified enzyme. J Biochem Biophys Methods 50:129-140
26. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
27. Conn PJ, Sanders-Bush E, Hoffman BJ, Hartig PR (1986) A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci USA 83:4086-4088
28. Lam DD, Heisler LK (2007) Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes. Expert Rev Mol Med 9:1-24. doi: 10.1017/S1462399407000245
29. Smrcka AV, Brown JH, Holz GG (2012) Role of phospholipase cepsilon in physiological phosphoinositide signaling networks. Cell Signal 24:1333-1343. doi: 10.1016/j.cellsig.2012.01.009
30. Ferris CD, Snyder SH (1992) IP3 receptors: ligand-activated calcium channels in multiple forms. Adv Second Messenger Phosphoprot Res 26:95-107
31. Marinho-Carvalho MM, Costa-Mattos PV, Spitz GA, Zancan P, Sola-Penna M (2009) Calmodulin upregulates skeletal muscle 6-phosphofructo-1-kinase reversing the inhibitory effects of allosteric modulators. Biochim et Biophys Acta 1794:1175-1180
32. Marinho-Carvalho MM, Zancan P, Sola-Penna M (2006) Modulation of 6-phosphofructo-1-kinase oligomeric equilibrium by calmodulin: formation of active dimers. Mol Genet Metab 87:253-261
33. Zancan P, Rosas AO, Marcondes MC, Marinho-Carvalho MM, Sola-Penna M (2007) Clotrimazole inhibits and modulates heterologous association of the key glycolytic enzyme 6-phosphofructo-1-kinase. Biochem Pharmacol 73:1520-1527
34. 2+/calmodulin protein kinase. Biochem Biophys Res Commun 174:1255-1259. doi: 10.1016/0006-291X(91)91556-R
35. Oufkir T, Arseneault M, Sanderson JT, Vaillancourt C (2010) The 5-HT 2A serotonin receptor enhances cell viability, affects cell cycle progression and activates MEK-ERK1/2 and JAK2-STAT3 signalling pathways in human choriocarcinoma cell lines. Placenta 31:439-447. doi: 10.1016/j.placenta.2010.02.019
36. Rane SG, Reddy EP (2000) Janus kinases: components of multiple signaling pathways. Oncogene 19:5662-5679. doi: 10.1038/sj.onc.1203925
37. Guillausseau PJ, Meas T, Virally M, Laloi-Michelin M, MÈdeau V, Kevorkian JP (2008) Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab 34:S43-S48
38. Coelho RG, Calaça IdC, Celestrini DdM, Correia AH, Costa MASM, Sola-Penna M (2011) Clotrimazole disrupts glycolysis in human breast cancer without affecting non-tumoral tissues. Mol Genet Metab 103:394-398. doi: 10.1016/j.ymgme.2011.04.003
39. Da Silva D, Zancan P, Coelho WS, Gomez LS, Sola-Penna M (2010) Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse. Arch Biochem Biophys 496:53-60. doi: 10.1016/j.abb.2010.01.013
40. El-Bacha T, de Freitas MS, Sola-Penna M (2003) Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer. Mol Genet Metab 79:294-299
41. Grechi J, Marinho-Carvalho M, Zancan P, Cinelli LP, Gomes AMO, Rodrigues ML, Nimrichter L, Sola-Penna M (2011) Glucuronoxylomannan from Cryptococcus neoformans down-regulates the enzyme 6-phosphofructo-1-kinase of macrophages. J Biol Chem 286:14820-14829. doi: 10.1074/jbc.M110.177030
42. Leite TC, Coelho RG, Silva DD, Coelho WS, Marinho-Carvalho MM, Sola-Penna M (2011) Lactate downregulates the glycolytic enzymes hexokinase and phosphofructokinase in diverse tissues from mice. FEBS Lett 585:92-98. doi: 10.1016/j.febslet.2010.11.009
43. Leite TC, Da Silva D, Coelho RG, Zancan P, Sola-Penna M (2007) Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis. Biochem J 408:123-130
44. Meira DD, Marinho-Carvalho MM, Teixeira CA, Veiga VF, Da Poian AT, Holandino C, de Freitas MS, Sola-Penna M (2005) Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes. Mol Genet Metab 84:354-362
45. Spitz GA, Furtado CM, Sola-Penna M, Zancan P (2009) Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem Pharmacol 77:46-53
46. Michaelidis B, Rofalikou E, Beis I (1993) The effect of serotonin (5-hydroxytryptamine) on glycolysis in the perfused ventricle of the fresh-water bivalve Anodonta cygnea: evidence for phosphorylation dephosphorylation control of phosphofructokinase. J Exp Biol 180:15-25
47. Shum JK, Melendez JA, Jeffrey JJ (2002) Serotonin-induced MMP-13 production is mediated via phospholipase C, protein kinase C, and ERK1/2 in rat uterine smooth muscle cells. J Biol Chem 277:42830-42840. doi: 10.1074/jbc.M205094200
48. 2+ release in the heart by activation of protein kinase cepsilon and calcium-calmodulin kinase II. J Biol Chem 284:1514-1522. doi: 10.1074/jbc.M806994200
49. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res 73:631-640. doi: 10.1016/j.cardiores.2006.11.005
50. Ase AR, Raouf R, Belanger D, Hamel E, Seguela P (2005) Potentiation of P2X1 ATP-gated currents by 5-hydroxytryptamine 2A receptors involves diacylglycerol-dependent kinases and intracellular calcium. J Pharmacol Exp Ther 315:144-154. doi: 10.1124/jpet.105.089045
51. 2+ sensitization in 5-hydroxytryptamine-evoked contraction of rabbit mesenteric artery. Br J Pharmacol 111:525-532
52. Cohen ML, Wittenauer LA (1987) Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle. J Cardiovasc Pharmacol 10:176-181
53. ++ channels and phospholipase C. J Pharmacol Exp Ther 234:442-446
54. Roth BL, Nakaki T, Chuang DM, Costa E (1986) 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester. J Pharmacol Exp Ther 238:480-485
55. 2+ on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeleton. Biochem Med Metab Biol 49:173-181
56. 2+-ionophore A23187 and calmodulin antagonists on regulatory mechanisms of glycolysis and cell viability of NIH-3T3 fibroblasts. Mol Genet Metab 67:334-342. doi: 10.1006/mgme.1999.2877
57. 2+ on erythrocyte membrane skeleton-bound phosphofructokinase, ATP levels, and hemolysis. Mol Genet Metab 66:56-61. doi: 10.1006/mgme.1998.2773
58. Orosz F, Christova TY, Ovadi J (1988) Functional in vitro test of calmodulin antagonism: effect of drugs on interaction between calmodulin and glycolytic enzymes. Mol Pharmacol 33:678-682
59. Orosz F, Kovacs J, Low P, Vertessy BG, Urbanyi Z, Acs T, Keve T, Ovadi J (1997) Interaction of a new bis-indol derivative, KAR-2 with tubulin and its antimitotic activity. Br J Pharmacol 121:947-954
60. Beitner R (1998) Calmodulin antagonists and cell energy metabolism in health and disease. Mol Genet Metab 64:161-168
61. Glass-Marmor L, Beitner R (1997) Detachment of glycolytic enzymes from cytoskeleton of melanoma cells induced by calmodulin antagonists. Eur J Pharmacol 328:241-248
62. Lilling G, Beitner R (1990) Decrease in cytoskeleton-bound phosphofructokinase in muscle induced by high intracellular calcium, serotonin and phospholipase A2 in vivo. Int J Biochem 22:857-863
63. Livnat T, Chen-Zion M, Beitner R (1993) Stimulatory effect of epidermal growth factor on binding of glycolytic enzymes to muscles cytoskeleton and the antagonistic action of calmodulin inhibitors. Biochem Med Metab Biol 50:24-34
64. Penso J, Beitner R (2002) Detachment of glycolytic enzymes from cytoskeleton of Lewis lung carcinoma and colon adenocarcinoma cells induced by clotrimazole and its correlation to cell viability and morphology. Mol Genet Metab 76:181-188
65. Penso J, Beitner R (2002) Clotrimazole decreases glycolysis and the viability of lung carcinoma and colon adenocarcinoma cells. Eur J Pharmacol 451:227-235
66. Furtado CM, Marcondes MC, Sola-Penna M, de Souza ML, Zancan P (2012) Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis. PLoS One 7:e30462. doi: 10.1371/journal.pone.0030462
67. Sola-Penna M (2008) Metabolic regulation by lactate. IUBMB Life 60:605-608
68. Marcondes MC, Sola-Penna M, RdSG Torres, Zancan P (2011) Muscle-type 6-phosphofructo-1-kinase and aldolase associate conferring catalytic advantages for both enzymes. IUBMB Life 63:435-445. doi: 10.1002/iub.464
69. Marcondes MC, Sola-Penna M, Zancan P (2010) Clotrimazole potentiates the inhibitory effects of ATP on the key glycolytic enzyme 6-phosphofructo-1-kinase. Arch Biochem Biophys 497:62-67. doi: 10.1016/j.abb.2010.03.013
70. McKune CM, Watts SW (2001) Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. J Pharmacol Exp Ther 297:88-95
71. Ogden K, Thompson JM, Hickner Z, Huang T, Tang DD, Watts SW (2006) A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction. Am J Physiol Heart Circ Physiol 291:H2857-H2863. doi: 10.1152/ajpheart.00229.2006
72. Honda H, Oda H, Nakamoto T, Honda Z, Sakai R, Suzuki T, Saito T, Nakamura K, Nakao K, Ishikawa T, Katsuki M, Yazaki Y, Hirai H (1998) Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet 19:361-365. doi: 10.1038/1246
73. Tang DD, Tan J (2003) Role of Crk-associated substrate in the regulation of vascular smooth muscle contraction. Hypertension 42:858-863. doi: 10.1161/01.HYP.0000085333.76141.33
74. Tang DD, Tan J (2003) Downregulation of profilin with antisense oligodeoxynucleotides inhibits force development during stimulation of smooth muscle. Am J Physiol Heart Circ Physiol 285:H1528-H1536. doi: 10.1152/ajpheart.00188.2003
75. 2A receptor-mediated contraction in rat aorta. J Physiol 586:3855-3869. doi: 10.1113/jphysiol.2008.153593
76. Quinn JC, Johnson-Farley NN, Yoon J, Cowen DS (2002) Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J Pharmacol Exp Ther 303:746-752. doi: 10.1124/jpet.102.038083